Deciphering Resistance: Beyond the Androgen Paradigm; Report From the 2025 Coffey‐Holden Prostate Cancer Academy Meeting
This meeting report summarizes the presentations from the 2025 CHPCA Meeting. We hope that disseminating this information will directly contribute to novel research efforts and improved treatment strategies for patients with prostate cancer.
Authors
- Saul J. Priceman (ORCID: https://orcid.org/0000-0002-8136-2112)
- Ashley E. Ross (ORCID: https://orcid.org/0000-0001-7044-9688)
- Rana R. McKay (ORCID: https://orcid.org/0000-0002-0581-7963)
- Howard R. Soule (ORCID: https://orcid.org/0000-0003-2255-2298)
- Phuoc T. Tran (ORCID: https://orcid.org/0000-0002-0147-0376)
- Tanya Ivanova Stoyanova (ORCID: https://orcid.org/0000-0003-0119-9747)
- Kenneth J. Pienta (ORCID: https://orcid.org/0000-0002-4138-2186)
- Andrea K. Miyahira (ORCID: https://orcid.org/0000-0003-4976-002X)
Institutions
- Northwestern University (US)
- University of Maryland, Baltimore (US)
- The University of Texas MD Anderson Cancer Center (US)
- Johns Hopkins University (US)
- University of California, Los Angeles (US)
- Prostate Cancer Foundation (US)
- University of California San Diego (US)
- Los Angeles Medical Center (US)
- USC Norris Comprehensive Cancer Center (US)
- Northwestern Medicine (US)
- Johns Hopkins Hospital (US)
- University of Baltimore (US)
Publication Details
- Journal
- The Prostate
- Published
- 2025-12-07
- DOI
- https://doi.org/10.1002/pros.70102
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- Prostate Cancer Foundation
- Neuroendocrine Tumor Research Foundation
- National Institutes of Health
- National Cancer Institute